F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Short Interest Update

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 11,453 shares, a decrease of 48.0% from the July 15th total of 22,041 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average trading volume of 4,707 shares, the short-interest ratio is currently 2.4 days.

F/m Emerald Life Sciences Innovation ETF Stock Performance

Shares of LFSC traded up $0.34 on Monday, reaching $47.42. 6,838 shares of the company’s stock traded hands, compared to its average volume of 4,733. F/m Emerald Life Sciences Innovation ETF has a 52-week low of $26.75 and a 52-week high of $47.68. The stock’s 50 day simple moving average is $44.58 and its two-hundred day simple moving average is $39.29.

Institutional Investors Weigh In On F/m Emerald Life Sciences Innovation ETF

An institutional investor recently raised its position in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC grew its stake in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 49,739 shares of the company’s stock after purchasing an additional 3,831 shares during the quarter. Hunter Associates Investment Management LLC owned approximately 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 at the end of the most recent quarter.

About F/m Emerald Life Sciences Innovation ETF

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.